Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2026-03-18T17:52:50.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:58:58.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the notices for Revision: v3.4.1 and the government funding lapse notice.
    Difference
    0.3%
    Check dated 2026-02-11T01:50:08.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Site-wide notice added about a lapse in government funding and NIH Clinical Center operations; Revision: v3.4.1 replaces v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-03T23:18:01.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    UI updates include displaying the glossary toggle and adding a 'Last Update Submitted that Met QC Criteria' label, and a 'No FEAR Act Data' note was added with the revision bumped to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-26T15:52:54.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Revision from v3.3.3 to v3.3.4 represents a minor update to the page, with no changes to study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-19T11:52:54.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.